Surgery Partners reports Q3 adjusted EPS 13c, consensus 18c

Reports Q3 revenue $821.5M, consensus $820.9M. Reports Q3 same-facility revenue up 6.3%. Eric Evans, Chief Executive Officer, stated, “We are proud to report another quarter of solid execution, with revenue and Adjusted EBITDA growth reflecting continued progress in line with our long-term growth algorithm. The continued strength in orthopedic procedures underpinning our topline growth reinforces our leading positioning within the industry, and we remain committed to operational excellence and disciplined capital deployment to maximize performance of our portfolio. We also continue to evaluate our M&A pipeline and portfolio optimization opportunities and remain encouraged by the multiple levers available to unlock value and drive sustained success.”